N-Methyl-(R)-salsolinol as a dopaminergic neurotoxin: From an animal model to an early marker of Parkinson's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 50, 1997, Pages 89-105

  Naoi, M ^a   Maruyama, W ^b   Dostert, P ^c   Hashizume, Y ^d  

^a NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c PFIZER INC   (United States)

^d AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SALSOLINOL DERIVATIVE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; DOPAMINE; ISOQUINOLINE DERIVATIVE; NEUROTOXIN; SALSOLINE; SALSOLINE DERIVATIVE; SALSOLINOL; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL CULTURE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENANTIOMER; HISTOLOGY; HUMAN; NEUROBLASTOMA; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVIEW; SUBSTANTIA NIGRA; ANIMAL; BRAIN; CELL LINE; CELL SURVIVAL; DRUG EFFECT; MALE; METABOLISM; PATHOLOGY; STEREOISOMERISM; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; CELL LINE; CELL SURVIVAL; DOPAMINE; HUMANS; ISOQUINOLINES; MALE; NEUROTOXINS; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; SALSOLINE ALKALOIDS; STEREOISOMERISM; TETRAHYDROISOQUINOLINES;

EID: 0030614651     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6842-4_10     Document Type: Review

References (49)

1. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquerz J, Mouatt-Prigient A, Ruberg M, Hirsch EC, Agid Y (1995) Apoptotic degeneration of nigral dopaminergic neurons in Parkinson's disease. Soc Neurosci Abstract 21: 1250
2. Azevedo I, Osswald W (1977) Adrenergic nerve degeneration induced by condensation products of adrenaline and acetaldehyde. Naunyn-Schmiedeberg's Arch Pharmacol 300: 139-144
3. Chiba K, Trevor AJ, Castagnoli N Jr (1984) Metabolism of the neurotoxic amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120: 574-578
4. Collins MA, Neafsey EJ, Matsubara K, Cobuzzi R Jr, Rollema H (1992) Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins. Brain Res 570: 154-160
5. Costal B, Naylor RJ, Pinder RM (1976) Hyperactivity induced by tetrahydroisoquinoline derivatives injected into the nucleus accumbens. Eur J Pharmacol 39: 153-160
6. D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH (1987) Evidence for neuromelanin involvement in MPTP-induced neurotoxicity. Nature 327: 324-326
7. Deng Y, Maruyama W, Dostert P, Takahashi T, Kawai M, Naoi M (1995) Determination of the (R)- and (S)-enantiomers of salsolinol and N-methylsalsolinol by use of a chiral HPLC column. J Chromatogr B 670: 47-54
8. Dostert P, Strolin Benedetti M, Dordain G, Vernay D (1989) Enantiometric composition of urinary salsolinol in Parkinsonian patients after Madopar. J Neural Transm [P-D Sect] 1: 269-278
9. Dostert P, Strolin Benedetti M, Bellotti V, Allievi C, Dordain G (1990) Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects. J Neural Transm [GenSect] 81: 215-223
10. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AHV (1994) Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: Relevance to Parkinson's disease. J Neurochem 63: 1987-1990
11. Jenner P, Schapira AHV, Marsden CD (1992) New insights into the cause of Parkinson's disease. Neurology 42: 2241-2250
12. Langston JW, Irwin I, Ricaurte GA (1987) Neurotoxins, parkinsonism and Parkinson's disease. Pharmac Ther 32: 19-49
13. Liptrot J, Holdup D, Phillipson O (1993) 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol depletes catecholamines in rat brain. J Neurochem 61: 2199-2206
14. Maruyama W, Nakahara D, Ota M, Takahashi T, Takahashi A, Nagatsu T, Naoi M (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study. J Neurochem 59: 395-400
15. Maruyama W, Naoi M (1994) Inhibition of tyrosine hydroxylase by a dopamine neurotoxin, 1-methyl-4-phenylpyridinium ion: Depletion of allostery to the biopterin cofactor. Life Sci 55: 207-212
16. Maruyama W, Dostert P, Matsubara K, Naoi M (1995a) N-Methyl(R)salsolinol produces hydroxyl radicals: Involvement to neurotoxicity. Free Rad Biol Med 19: 67-75
17. Maruyama W, Dostert P, Naoi M (1995b) Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: In vivo and in vitro studies . J Neurochem 64: 2635-2643
18. Maruyama W, Abe T, Tohgi H, Dostert P, Naoi M (1996) A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian CSF. Ann Neurol 40: 119-122
19. Matsubara K, Neafsey EJ, Collins MA (1992) Novel S-adenosylmethionine-dependent indole-N-methylation of β-carbolines in brain particulate fractions. J Neurochem 59: 511-518
20. McNaught K, Thull U, Carrupt P-A, Altomare C, Cellamare S, Carotti A, Testa B, Kenner P, Marsden CD (1995) Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem Pharmacol 50: 1903-1911
21. Mizuno Y, Saitoh T, Sone N (1987) Inhibition of mitochondrial NADH-ubiquinone oxido-reductase activity by 1-methyl-4-phenyl-pyridinium ion. Biochem Biophys Res Commun 143: 294-299
22. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163: 1450-1455
23. Mochizuki H, Goto G, Mori H, Mizuno Y (1996) Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 137: 120-123
24. Myers RD, Oblinger MM (1977) Alcohol drinking in the rat induced by acute intracerebral infusion of two tetrahydroisoquinolines and a β-carboline. Drug Alcohol Depend 2: 469-483
25. Nagatsu T, Yoshida M (1988) An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 87: 178-182
26. Naoi M, Takahashi T, Nagatsu T (1988) Simple assay procedure for tyrosine hydroxylase activity by high-performance liquid chromatography employing coulometric detection with minimal sample preparation. J Chromatogr 427: 229-238
27. Naoi M, Matsuura S, Takahashi T, Nagatsu T (1989) An N-methyltransferase in human brain catalyzes N-methylation of 1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion. Biochem Biophys Res Commun 161: 1213-1219
28. Naoi M, Maruyama W, Acworth IN, Nakahara D, Parvez H (1993) Multi-electrode detection system for determination of neurotransmitters. In: Parvez H, Naoi M, Nagatsu T, Parvez S (eds) Methods in neurotransmitter and neuropeptide research vol I. Elsevier, Amsterdam, pp 1-39
29. Naoi M, Maruyama W, Dostert P (1994a) Binding of 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion to melanin: effects of ferrous and ferric ion on the binding. Neurosci Lett 171: 9-12
30. Naoi M, Maruyama W, Niwa T, Nagatsu T (1994b) Novel toxins and Parkinson's disease: N-Methylation and oxidation as metabolic bioactivation of neurotoxin. J Neural Transm [Suppl] 41: 197-205
31. Naoi M, Maruyama W, Dostert P, Nakahara D, Takahashi T, Nagatsu T (1995a) Metabolic bioactivation of endogenous isoquinolines as dopaminergic neurotoxins to elicit Parkinson's disease. In: Hanin IS, Yoshida M, Fisher A (eds) Alzheimer's and Parkinson's diseases. Recent Developments. Plenum, New York, pp 553-559
32. Naoi M, Maruyama W and Dostert P (1995b) Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines: Oxidation and neurotoxicity. Prog Brain Res 106: 227-239
33. Naoi M, Maruyama W, Zhang JH, Takahashi T, Deng Y, Dostert P (1995c) Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion. Life Sci 57: 1061-1066
34. Naoi M, Maruyama W, Dostert P, Hashizume Y, Takahashi T, Ota M (1996a) Dopamine-derived endogenous 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rats: Biochemical, pathological and behavioral studies. Brain Res 709: 285-295
35. Naoi M, Maruyama W, Dostert P, Hashizume Y (1996b) Animal model of Parkinson's disease induced by naturally-occurring 1(R), 2(N)-dimelhyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. Biogenic Amines 12: 135-147
36. Nitta A, Murase Y, Furukawa Y, Hayashi K, Hasegawa T, Nabeshima T (1993) Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats. Neurosci 57: 495-499
37. Niwa T, Tekeda T, Yoshizumi H, Tatematsu A, Yoshida M, Dostert P, Naoi M, Nagatsu T (1991) Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-t,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains. Biochem Biophys Res Commun 177: 603-609
38. Origitano T, Hanningen J, Collins MA (1981) Rat brain salsolinol and blood-brain barrier. Brain Res 224: 446-451
39. Ostling O, Johanson KJ (1984) Microelectrophoretic sludy of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 123: 291-298
40. Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GD, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515-520
41. Sällström Baum S, Rommelspracher H (1994) Determination of total dopamine, R- and S-salsolinol in human plasma by cyclodextrin bonded-phase liquid chromatography with electrochemical detection. J Chromatogr B 660: 235-241
42. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827
43. Singer TP, Castagnoli N Jr, Ramsay RR, Trevor AJ (1987) Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 49: 1-8
44. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191
45. Sjöquist B, Eriksson A, Winblad B (1982) Salsolinol and catecholamines in human brain and their relation to alcoholism. Prog Clin Biol Res 90: 57-67
46. Strolin Benedetti M, Bellotti V, Pianezola E, Moro E, Carminati P, Dostert P (1989) Ratio of the R and S enantiomers of salsolinol in food and human urine. J Neural Transm 77: 47-53
47. Suzuki K, Mizuno Y, Yamauchi Y, Nagatsu T, Yoshida M (1992) Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-telrahydroisoquinoline in isolated mitochondria prepared from mouse brain. J Neurol Sci 109: 219-223
48. Takahashi T, Deng Y, Maruyama W, Dostert P, Kawai M, Naoi M (1994) Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J Neural Transm [GenSect] 98: 107-118
49. Tipton KF, Singer TP (1993) Advances in our understanding of the mechanism of the neurotoxicity of MPTP and related compounds. J Neurochem 61: 1191-1206